Home
About Us
Our Approach
Our Team
Board
Pipeline
News
Honor
Careers
Collaboration
Investor Relations
Disclosure
Contact IR
Contact
中文
ENG
Home
About us
Our Approach
Our Team
Board
Pipeline
News
Honor
Careers
Collaboration
Investor Relations
Disclosure
Contact IR
Contact
CN
TOGETHER,WE SEARCH FOR THE CURE
TOGETHER,WE SEARCH FOR THE CURE
Discover More
80余名
科研人员
40余项
PCT专利
23项
新药专利
ABOUT
TYK Medicines
Focus on new drug research and development
Together, we search for the cure.
Discover More
NEWS
TYK Medicine’s CDK7 Inhibitor TY-2699a Receives CDE Clinical Approval for Combination Therapy
Discover More
TYK Medicine’s CDK2 Inhibitor Receive Clinical Approval from CDE for Combination Therapy
Discover More
The Results of Asandeutertinib Tablets (TY-9591) will be Presented at the WCLC 2024
Discover More
RESEARCH
An innovative biotechnology company focusing on the research and development of innovative drugs
Discover More
